Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation.
Michael G CollinsMagid A FahimElaine M PascoeKathryn B DansieCarmel M HawleyPhilip A ClaytonKirsten HowardDavid W JohnsonColin J McArthurRachael C McConnochiePeter F MountDonna ReidlingerLaura RobisonJulie VargheseLiza A VergaraLaurence WeinbergSteven J Chadbannull nullPublished in: Trials (2020)
Australian New Zealand Clinical Trials Registry: ACTRN12617000358347. Registered on 8 March 2017. ClinicalTrials.gov: NCT03829488. Registered on 4 February 2019.